{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:38:32Z","timestamp":1789349912116,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.nbd.2007.03.011","type":"journal-article","created":{"date-parts":[[2007,4,25]],"date-time":"2007-04-25T14:20:47Z","timestamp":1177510847000},"page":"36-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Biological abnormalities of peripheral A2A receptors in a large representation of polyglutamine disorders and Huntington's disease stages"],"prefix":"10.1016","volume":"27","author":[{"given":"K.","family":"Varani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-C.","family":"Bachoud-L\u00e9vi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tarditi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Abbracchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Gasperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Borea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Dolbeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gellera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Solari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Naji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Handley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maccarrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Peschanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"DiDonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2007.03.011_bib1","doi-asserted-by":"crossref","first-page":"12212","DOI":"10.1074\/jbc.M411642200","article-title":"Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis.","volume":"280","author":"Bari","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2007.03.011_bib2","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.4049\/jimmunol.177.8.4971","article-title":"Effect of lipid rafts on CB2 receptor signaling and 2-arachidonoylglycerol metabolism in human immune cells","volume":"177","author":"Bari","year":"2006","journal-title":"J. Immunol."},{"issue":"31","key":"10.1016\/j.nbd.2007.03.011_bib5","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1073\/pnas.0504921102","article-title":"Genome-wide expression profiling of human blood reveals biomarkers for Huntington\u2019s disease","volume":"102","author":"Borovecki","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2007.03.011_bib8","first-page":"475","article-title":"Errors in Huntington disease diagnostic test caused by trinucleotide deletion in the IT15 gene","volume":"59","author":"Gellera","year":"1996","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.nbd.2007.03.011_bib9","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1212\/WNL.44.8.1533","article-title":"Guidelines for the molecular genetics predictive test in Huntington\u2019s disease","volume":"44","author":"International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington\u2019s Chorea","year":"1994","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nbd.2007.03.011_bib10","first-page":"81","article-title":"International Huntington\u2019s disease Collaborative Group. 2004. A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length","volume":"66","author":"Langbehn","year":"2004","journal-title":"Clin. Genet."},{"key":"10.1016\/j.nbd.2007.03.011_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/bbrc.1995.1519","article-title":"Role of lipid peroxidation in electroporation-induced cell permeability","volume":"209","author":"Maccarrone","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.nbd.2007.03.011_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2005.09.037","article-title":"The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington\u2019s disease patients with predominant chorea","volume":"393","author":"Maglione","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2007.03.011_bib13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1212\/WNL.54.2.452","article-title":"Rate of functional decline in Huntington\u2019s disease. Huntington Study Group","volume":"54","author":"Marder","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nbd.2007.03.011_bib15","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/S0006-3495(97)78887-8","article-title":"Two-photon fluorescence microscopy of laurdan generalized polarization domains in model and natural membranes","volume":"72","author":"Parasassi","year":"1997","journal-title":"Biophys. J."},{"issue":"10","key":"10.1016\/j.nbd.2007.03.011_bib17","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.31.10.1333","article-title":"Huntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugs","volume":"31","author":"Shoulson","year":"1981","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nbd.2007.03.011_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2006.01.014","article-title":"Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease","volume":"23","author":"Tarditi","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.nbd.2007.03.011_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-510X(96)00231-6","article-title":"International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology","volume":"145","author":"Trouillas","year":"1997","journal-title":"J. Neurol. Sci."},{"issue":"24","key":"10.1016\/j.nbd.2007.03.011_bib20","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1093\/hmg\/ddl434","article-title":"Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo","volume":"15","author":"Trushina","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2007.03.011_bib21","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","article-title":"Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease","volume":"25","author":"Valenza","year":"2005","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.nbd.2007.03.011_bib22","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/sj.bjp.0701758","article-title":"[3H]-SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes","volume":"123","author":"Varani","year":"1998","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.nbd.2007.03.011_bib25","doi-asserted-by":"crossref","first-page":"12457","DOI":"10.1096\/fj.00-0730fje","article-title":"Aberrant amplification of A(2A) receptor signaling in striatal cells expressing mutant huntingtin","volume":"15","author":"Varani","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2007.03.011_bib23","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1096\/fj.03-0079fje","article-title":"Aberrant A2A receptor function in peripheral blood cells in Huntington\u2019s disease","volume":"17","author":"Varani","year":"2003","journal-title":"FASEB J."},{"issue":"52","key":"10.1016\/j.nbd.2007.03.011_bib24","doi-asserted-by":"crossref","first-page":"13548","DOI":"10.1523\/JNEUROSCI.3554-06.2006","article-title":"Forebrain adenosine A2A receptors contribute to L-3,4-dihydroxyphenylalanine-induced dyskinesia in hemiparkinsonian mice","volume":"26","author":"Xiao","year":"2006","journal-title":"J. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996107000782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996107000782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:00:12Z","timestamp":1760850012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996107000782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0969996107000782"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2007.03.011","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological abnormalities of peripheral A2A receptors in a large representation of polyglutamine disorders and Huntington's disease stages","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2007.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}